Discovery of increased epidermal DNAH10 expression after regeneration of dermis in a randomized with-in person trial - reflections on psoriatic inflammation by Lagus, Heli et al.
1Scientific RepoRtS |         (2019) 9:19136  | https://doi.org/10.1038/s41598-019-53874-z
www.nature.com/scientificreports
Discovery of increased epidermal 
DNAH10 expression after 
regeneration of dermis in a 
randomized with-in person 
trial — reflections on psoriatic 
inflammation
Heli Lagus1, Mariliis Klaas2, Susanna Juteau3, Outi elomaa4,5, Juha Kere6, Jyrki Vuola1, 
Viljar Jaks2 & esko Kankuri7*
Because molecular memories of past inflammatory events can persist in epidermal cells, we evaluated 
the long-term epidermal protein expression landscapes after dermal regeneration and in psoriatic 
inflammation. We first characterized the effects of two dermal regeneration strategies on transplants 
of indicator split-thickness skin grafts (STSGs) in ten adult patients with deep burns covering more 
than 20% of their body surface area. After fascial excision, three adjacent areas within the wound were 
randomized to receive a permanent dermal matrix, a temporary granulation-tissue-inducing dressing or 
no dermal component as control. Control areas were covered with STSG immediately, and treated areas 
after two-weeks of dermis formation. Epidermis-dermis-targeted proteomics of one-year-follow-up 
samples were performed for protein expression profiling. Epidermal expression of axonemal dynein 
heavy chain 10 (DNAH10) was increased 20-fold in samples having had regenerating dermis vs control. 
Given the dermal inflammatory component found in our dermal regeneration samples as well as in early 
psoriatic lesions, we hypothesized that DNAH10 protein expression also would be affected in psoriatic 
skin samples. We discovered increased DNAH10 expression in inflammatory lesions when compared 
to unaffected skin. Our results associate DNAH10 expression with cell proliferation and inflammation 
as well as with the epidermal memory resulting from the previous regenerative signals of dermis. This 
study (ISRCTN14499986) was funded by the Finnish Ministry of Defense and by government subsidies 
for medical research.
Cellular and molecular interactions in the skin are crucial for preserving structure and functionality of the epi-
dermis, the skin’s outer boundary to the external world1. Epidermal cells undergo a coordinated process of differ-
entiation and apoptosis as they migrate to their demise, from the basement membrane separating epidermis from 
the underlying dermis2–4. The basement membrane anchors basal keratinocytes and regulates cell trafficking and 
diffusion of bioactive molecules5. The dermis, rich in extracellular matrix, nerves, and vasculature, nurtures the 
epidermis from below and produces critical paracrine signals to assist maintenance and regulation of epidermal 
structure and homeostasis6–9.
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Signals and pathways that mediate regulating epidermal-dermal interactions include members of Wnt10 and 
sonic hedgehog11 pathways, several growth factors, and cytokines and their receptors12–14, as well as cell-cell juxta-
crine signaling by, for example, the Notch pathway15. Epidermal cells utilize highly conserved membranous struc-
tures, such as the primary cilia, to translate these signals for control of critical cellular responses e.g., proliferation, 
migration, and differentiation16–19. Especially during wound healing, signaling between the epidermal and dermal 
compartments is highly activated20–22. After wound healing, memory of the wound persists as molecular level 
changes in epidermal T-cells23,24 and in epithelial stem cells25,26. Very little is known about epidermal responses 
and molecular memory after regeneration of the entire dermis in humans.
Skin regeneration follows a path similar to wound healing beginning with the formation of granulation tis-
sue—an initial inflammatory, vascularized, and highly proliferative dermal template—to support the epidermis. 
Here, we employed a clinical setting to investigate long-term epidermal reactivity in response to complete dermal 
regeneration (Fig. 1). We extend our results to a pathological perspective of dermal inflammation in skin samples 
collected from lesional and non-lesional sites of psoriatic skin, as well as from healthy control skin27,28.
Results
Proteins identified in skin grafts. We identified 481 proteins by untargeted, non-labelled proteomics of 
epidermal and dermal samples (The mass spectrometry proteomics data are available via the PRIDE29 partner 
repository with dataset identifier PXD010852; www.proteomexchange.org). All samples were subjected to blind 
clustering analysis to validate the ability of the microdissection procedure to distinguish between epidermis and 
dermis (Supplementary Table S1A n = 131 and B n = 181; with predominant proteins both in epidermis and der-
mis and Fig. S1 heat maps of proteins of all groups (Fig. S1A) and of epidermal and dermal proteins (Fig. S1B)). 
The volcano plots of proteins detectable across samples in epidermis and dermis are shown in Fig. 2 (upper 
panels). We found 30 proteins in epidermal and 24 proteins in dermal samples that were differentially expressed 
across treatment groups. The heat maps of these differentially expressed proteins (DEPs) are shown in the lower 
panels of Fig. 2. Of all proteins identified, 12% were significantly differently expressed between the treatment sites.
Early granulation tissue and dermal substitute increased the motor protein DNAH10 long-term 
expression in skin-graft keratinocytes. The most striking significant difference among epidermal pro-
teins was the expression of DNAH10 protein, with a 34-fold difference between the control group with the lowest 
and the cellulose-sponge-treated group with induced granulation tissue (IGT group) with the highest expression 
values. Although the expression of an acidic (type I) cuticular hair keratin 34, KRT34, demonstrated an immense 
448-fold increase in artificial dermal matrix (ADM)-treated samples compared to control, and a 119-fold dif-
ference between the ADM and IGT groups, only the 14-fold change in the IGT group vs control group attained 
statistical significance, possibly due to small sample size in ADM group. Caspase-14 (CASP14), a marker for 
keratinocyte differentiation, showed decreased expression in groups with dermal manipulation compared to the 
control group. The most differently expressed proteins in epidermis are shown in Fig. 3 panels A and C, and the 
most differently expressed proteins in dermis in panels B and D (Supplementary Fig. S2 shows functions and 
diseases associated with these proteins, and Table S2 DEPs).
In order to validate the findings from the proteomic data, the corresponding tissue sections were immuno-
histochemically stained using anti-DNAH10 and anti-CASP14 antibodies. Although the differences seen with 
immunohistochemistry were less distinct than in the proteomic analyses, the control group similarly showed the 
least staining for DNAH10 with significant differences compared to the other treatment groups (Fig. 4).
In samples receiving dermal components, DNAH10 staining demonstrated a tendency for an aberrant or 
biphasic cytosolic pattern with staining observed in the basal layer as well as in the upper layers (stratum granulo-
sum), while staining remained less intensive for DNAH10 in the thickest layer, stratum spinosum. In the control 
samples, the DNAH10 staining intensity remained at low levels and a similar staining pattern to that seen in the 
samples treated with dermal component manipulation was not observed. For CASP14, the control group showed 
most staining. This corroborates the difference found in the proteomics analysis.
To further investigate the role of DNAH10 and its association to different biological processes, such as prolif-
eration and formation of basement membrane, immunohistochemical staining was performed to detect prolifera-
tion using antibodies against the Ki-67 (clone MIB-1) and basement membrane protein collagen type IV antigens. 
An inverse relationship between DNAH10 and MIB-1 was detected. Staining for collagen type IV also showed an 
inverse relationship to MIB-1 staining (Fig. 4).
DNAH10 is associated with epithelial cell proliferation and differentiation. We performed path-
way and network analysis for the epidermal DEPs using Ingenuity Pathway Analysis (IPA) software. Proteins with 
increased expression across comparisons, including DNAH10, were associated with pathways such as prolifera-
tion of epithelial cells, differentiation of hair cells, and epithelial barrier formation (Supplementary Fig. S3). The 
Diseases and Functions-category listings by IPA that demonstrated the strongest associations with the DEPs are 
shown in Supplementary Fig. S2 and Supplementary Table S3.
The analysis of the DNAH10 promoter region to predict transcription factor (TF) binding sites was per-
formed using TRANSFAC (Supplementary Table S4). The transcription factors AP-2, KLF-6, and ZF-5 had most 
binding sites within the promoter. All three TFs regulate cell proliferation and differentiation. The DNAH10 
gene on chromosome 12 has ten splice variants, six of which yield protein products (Supplementary Table S5). 
The transcripts DNAH10-210 and DNAH10-201 produce the large dynein proteins with molecular weights 
of 500 kDa, whereas the transcript variants DNAH10-205, −207, and −209 yield smaller proteins (molec-
ular weights ranging from 35 to 115 kDa). Our proteomics profiling identified a unique peptide sequence 
“LESIFIGGDIRSQLPEEAKKFDNIDKVF” for the differentially expressed DNAH10. This sequence is present in 
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the high molecular weight protein products of DNAH10, whereas only the DNAH10-205 variant of transcripts 
yielding low molecular weight proteins includes this sequence (Supplementary Table S6).
Mitomycin C-treatment increases the expression of DNAH10 in cultured primary keratinocytes. 
To further examine the association between proliferation and DNAH10 expression, cultured early passage (P3) 
primary keratinocytes were treated with mitomycin C (5 µg/ml) for three hours and the expression of DNAH10 
was evaluated after 24 hours with Western blot (Fig. 5A) and immunofluorescence staining (Fig. 5B). Mitomycin 
C is an antineoplastic agent that inhibits DNA synthesis in various mammalian cells. Both Western blot and 
immunocytochemistry showed high DNAH10 expression in the mitomycin C treatment group vs control.
Figure 1. (A) Timeline of the treatment protocol. 0 week: After excision to fascial level the wound bed of the C 
group (the top row) was covered with STSG, ADM group (the middle row) with dermal matrix Integra and IGT 
group (the bottom row) with a temporary dressing of viscose cellulose sponge Cellonex. 1 week: IGT group: 
cellulose sponge was changed to a new one. 2 weeks: ADM group: Silicone layer of dermal matrix was replaced 
with a STSG, IGT group: cellulose sponge was replaced with STSG. 1 year: Punch biopsies of each study section 
were gathered. Illustration made by Sole Lätti. (B) CONSORT flow diagram
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Treatments with TGF-β1 and TNFα decrease DNAH10 expression in cultured primary kerati-
nocytes. The protein expression of DNAH10 was assessed by Western blot analysis after stimulation of pri-
mary keratinocytes (P4) with inflammatory cytokine TNFα or growth factor TGF-β1 and their combination 
(Fig. 5C). Both stimulants are multitasking proteins known to take part in wound healing, affect keratinocyte 
proliferation, and cause cell-cycle arrest. Treatment with TNFα, TGF-β1, and their combination down regulated 
the expression of DNAH10 in keratinocytes after a 24-h-stimulation. DNAH10 expression levels were as follows: 
control (100%) > TGF-β1 (71%, SD 6.9%) > TNFα (46%, SD 9.9%) > combination of TGF-β1 and TNFα (40%, 
SD 17.0%).
DNAH10 protein expression is increased in psoriatic lesions. Using IPA, we associated the increased 
expression of DNAH10 in STSGs of dermis-manipulated groups vs control, with biological networks relating 
to proliferation, differentiation, and barrier function. Moreover, we found DNAH10 protein expression to be 
regulated by cytokine stimulation in primary human keratinocytes. Based on these results, we hypothesized that 
expression of DNAH10 would be affected in active psoriatic epidermis characterized by early dermal inflam-
mation, keratinocyte hyperproliferation, and defective epidermal barrier function30–32. Moreover, for our previ-
ous work on psoriasis and keratinocytes27,28,33 we had collected specifically thin STSG samples from both active 
inflamed and normal skin areas. To investigate whether DNAH10 would be differently present or distributed in 
normal skin, in samples of healthy controls compared to those of both lesional and non-lesional skin of psoriasis 
patients, the samples were immunohistochemically stained with anti-DNAH10 antibody. Expression of DNAH10 
Figure 2. Volcano plots (upper panels) and heat maps (lower panels) of proteins in epidermis (A) and dermis 
(B). Values selected separately for highest significance (y-axis/−log, p-value) and greatest fold change (x-axis/
log2) across all comparisons between groups. Horizontal dotted line, p = 0.05. Vertical dotted lines, fold 
change = ±2. Lower panels heat maps show proteins expressed significantly differently (p > 0.05) in these three 
different treatment groups (IGT, ADM, and control).
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in lesional psoriatic samples was significantly higher than in either healthy control samples or non-lesional sam-
ples of psoriatic patients (Fig. 6).
The samples from healthy controls without psoriasis tended to demonstrate a similar cytosolic epithelial stain-
ing pattern as that observed in the samples receiving additional dermal components (Fig. 4C). A similar pattern 
was also observed in the psoriasis patient’s non-lesional epidermis. However, DNAH10 staining in the epidermis 
Figure 3. Differentially expressed proteins in comparison between the test-groups measured in relative 
intensity in mass-spectrometry of all proteins identified. Panels A and C show proteins with quantified 
abundant expression in epidermis and dermis respectively. Panels B and D show proteins with quantified low 
expression levels in epidermis and dermis respectively.
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of the lesional skin showed less pronounced patterning, suggesting that psoriasis-associated alterations may dis-
rupt DNAH10 expression patterning.
We then reviewed previous RNA sequencing data of psoriatic skin samples28,34,35. This review demonstrated 
that axonemal heavy chain dynein genes, including DNAH10, were not among the differentially expressed genes 
when comparing psoriatic lesional and non-lesional thin skin grafts. Down regulation was seen, however, in the 
lesional samples when analyzed from the full thickness skin samples including dermis. However, several other 
dynein genes as well as kinesin genes showed upregulation in lesional skin when compared to non-lesional sam-
ples (Supplementary Table S7).
Discussion
Dermal signals and support are crucial for function, maturation, maintenance, and repair of the overlaying epi-
dermal protective barrier layer. Here we utilized a clinical setup with three dermal compartments, on top of 
which autologous mainly epidermis-containing indicator tissues were transplanted. The sites were randomized 
to receive no additional dermal support, a permanent acellular dermal substitute, or a temporary dressing of 
viscose cellulose to induce granulation tissue formation. At one-year follow-up the gross clinical appearances of 
the treatment sites were equal36, but we observed specific early differences between treatment sites37. At one-week 
follow-up, dermal cells in both the granulation tissue and artificial dermal template proliferated actively, while 
such proliferative activity was only observed after three months at sites without additional dermal support37. In 
one-year follow-up samples, 12% of the proteins identified were differently expressed between treatment sites. 
We discovered greatly increased expression of a dynein protein, DNAH10, in epidermis predisposed to an active 
dermal component. There was also an evident trend for increased expression of KRT34 in both groups receiving 
dermal pretreatment compared to the control group, suggesting that dermal pretreatment may promote hair 
follicle maintenance38.
Figure 4. Immunohistochemistry of STSGs 1 year after operation. (A) Diagram of DNAH10 staining in  
control group (C), with no additional treatment of wound bed and in manipulated wound beds ADM and IGT.  
(B) Pictures of STSGs of DNAH10- staining: left on ADM, in the middle control and on right on IGT.  
(C) CASP14 is a marker for differentiation of keratinocytes. (D) Proliferation marker MIB-1 showed positively 
stained particles corresponding cell nuclei/picture. The slides were scanned with the 20x air objective, images 
were captured with the magnification 65 (±1.4)x scanned slides. (E) Basement membrane component type IV 
collagen staining. In all diagrams error bars present mean +/−SEM.
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DNAH10 expression has been found in cilia and flagella39. Dyneins are multisubunit motor proteins that are 
associated with processes including microtubule transport, axonemal and ciliary signaling39, as well as chem-
osensory perception40 and cell migration41. DNAH proteins have also been linked to various cancers42. Axonemal 
dyneins, associated with the axonemes of primary cilia, are found in most human cells during G0/G1 and at the 
beginning of S phase, mainly in differentiated cells or in resting stem cells40. The primary cilium is resorbed in 
cells that re-enter the cell cycle and grows again on each daughter cell during the quiescent period40. Primary 
cilia transduce juxta- and paracrine signals to modulate key processes like cell survival, proliferation, migration, 
differentiation, and innate immunity. They mediate signals from various cascades and associate with pathways 
including the TGF-β pathway as well as the Hedgehog, Wnt, Notch, and Hippo signaling pathways43,44.
We demonstrated that the expression of DNAH10 was affected by mitomycin C, a DNA synthesis and 
cell-cycle inhibitor, in early passage primary cultures of normal human keratinocytes. Intriguingly, we observed 
increased DNAH10 staining overnight after the cells were transiently treated with the cell proliferation inhibi-
tor mitomycin C. We also showed that treatment with TNFα, TGF-β1, and their combination led to a decrease 
in DNAH10 expression in cultured primary keratinocytes. Especially in the skin, TNFα and TGF-β1 have a 
pro-inflammatory role45,46. TNFα may sensitize cells to additional stimuli that determine whether the kerat-
inocytes will undergo apoptosis, differentiation, or proliferation47. Thus, the cytokines’ suppressive action on 
DNAH10 expression in normal keratinocytes and the increased expression of DNAH10 in epidermis of psoriasis 
lesions suggest differential regulation of DNAH10 expression in normal keratinocytes and psoriatic epidermis, 
Figure 5. Effect of induction of cell cycle arrest on DNAH10 expression in keratinocytes. (A,B) Primary 
keratinocyte cell cultures treated with or without mitomycin C (5 μg/ml) for 3 hours. After 24-hour incubation 
in culture media DNAH10 expression in keratinocytes shown both in Western blot (A) and immunofluorence 
cytochemistry (B) after 24-hour incubation in culture media shown in 200 x magnification power.  
(C) Keratinocyte culture stimulation with TNFα, TGF-β1, and both together for 24 hours shown in relative 
intensity of DNAH10 expression in Western blot. In Western blots n = 3–4.
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or even a dysregulation in psoriatic epidermis. Future elucidation of the mechanism of DNAH10 expressional 
regulation can be expected to unravel physiological and pathological, as well as acute and delayed expression 
differences, and possibly to unveil novel anti-inflammatory and anti-aging therapeutic targets.
Our findings demonstrated long-term increased expression of epidermal DNAH10 protein triggered by der-
mal signaling in a healing wound. We associated DNAH10 expression with cell proliferation, migration, and 
differentiation of keratinocytes, as well as inflammation. Because psoriasis, a hyperproliferative, inflammatory 
skin disorder with defects in epidermal differentiation and barrier function29,46 shows similar biological pathway 
associations, we hypothesized that the expression of epidermal DNAH10 would be differentially regulated as 
compared to normal or non-lesional skin. In the early stages of psoriatic plaques, dermal involvement is domi-
nant, including immune-cell infiltration and production of TNFα as one of the main executor cytokines in psori-
asis. TNFα regulates not only immune and inflammatory responses, but also tissue remodeling, cell motility, cell 
cycle, and apoptosis47. We discovered a significantly increased expression of DNAH10 in the lesional epidermis as 
compared to non-lesional epidermis or to epidermis of non-psoriatic patients. The tendency to aberrant biphasic 
or dual pattern of DNAH10 staining across the depth of the epidermis as observed in normal control epider-
mis, psoriatic epidermis, and during wound healing, suggests that DNAH10 expression is activated at specific 
times during keratinocyte differentiation. DNAH10 expression may associate with the progress of keratinocytes 
through epidermal layers during the epidermal differentiation process. The expression of axonemal dyneins has 
already been linked to cell differentiation and correlated with the appearance of a ciliated phenotype48. The results 
of this study highlight the need to elucidate the roles of primary cilia and the axoneme in the epidermis and the 
functional role of the axonemal dyneins during epidermal differentiation. These findings will increase our under-
standing of the intricate signaling networks and signaling pathways orchestrating the formation and integrity of 
the skin. Less intense staining in the stratum spinosum upon loss of cell-matrix contacts, followed by reinstated 
DNAH10 expression in the upper layers with reinforced cell-cell contacts, suggests the association of DNAH10 
expression with processes and molecules especially related to the maintenance of cell contacts and adherence. 
Cell-cell and cell-matrix contacts are critically important in communication between homotypic and heterotypic 
cells, as well as in communication between the cells and their microenvironment. Cell-cell contacts, e.g. tight 
junctions in stratum granulosum and corneodesmosomes in stratum corneum, contribute to the formation of 
physical barriers crucial for the protective barrier function. Interestingly, tight junctions start to assemble only in 
granular cells, not in the spinous layer where the DNAH10 expression is lower49.
Figure 6. DNAH10 immunohistochemistry of STSGs of psoriasis patients, lesional and non-lesional samples, 
compared to the samples of healthy individuals. The slides were scanned with 20x air objective and images were 
captured with the magnification 65 (±1.4)x scanned slides.
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The induction of DNAH10 protein expression remained undetected at the mRNA level in previous studies 
based on RNA sequencing, suggesting that DNAH10 expression is controlled at a post-translational level. The 
size of the DNAH10 protein (515 kDa) can either directly or indirectly contribute to slow cycling and expres-
sional changes of the protein. Moreover, we identified here by mass-spectrometry a unique DNAH10 peptide 
which could be encoded by a shorter transcript variant DNAH10-205. Interestingly this transcript is subject to 
nonsense-mediated decay (NMD)50–52 suggesting its escape and a contribution of the NMD pathway to DNAH10 
or DNAH10-205 expression in the long-term memory response. The post-translational modification may reg-
ulate the expression pattern of DNAH10, similarly as diverse post-translational modifications of tubulin con-
trol the specialization of microtubules. This biological regulation known as the tubulin code53 may well have 
an analogous “dynein code” that regulates the dynein protein’s function and stability. Deciphering the enigma 
of post-translational “dynein code”, as well as the transcriptional and post-transcriptional events in epidermal 
activation and differentiation (e.g., transcripts escaping NMD51,54, could yield intriguing new insights into the 
physiological and pathological aspects of epithelial-mesenchymal interactions.
We also analyzed the promoter sequence of DNAH1055 using the TRANSFAC resource, and found binding 
sites to transcription factors, such as AP-2, Kruppel like factor 6 (KLF-6), and ZF5 (ZBTB14) that generally reg-
ulate cell proliferation, differentiation, and apoptosis. The AP-2 family belongs to key regulators of ectodermal 
development and skin differentiation56. This analysis further strengthens the association of DNAH10 with kerat-
inocytes’ cell cycle control. Elucidating the factors guiding DNAH10 gene expression, as well as specific control 
of DNAH10 at the post-translational level can be expected to yield unprecedented insights into the physiological 
and pathological roles of long-term memory of epidermal-mesenchymal interactions. This will lead to the dis-
covery of early diagnostic markers or drug targets for inflammation or altered cell proliferation as observed in 
precancerous lesions.
Epidermal stem cells can remember earlier inflammation by maintaining changes in their chromosomes and 
thus recurrent tissue damage triggers accelerated wound healing and hastened barrier restoration25. This altered 
genetic memory is considered to be beneficial, but may predispose to skin cancers or lead to autoimmune dis-
orders of skin, like psoriasis and atopic dermatitis25. It is intriguing to speculate that such epidermal stem cell’s 
memory could explain the differences seen in thin superficial split-thickness skin grafts, even one year after the 
operation on dermal compartments, offering different early cues. The molecular changes associated with long 
term memory of epidermal cells may present as targets for therapeutic interventions to correct awry memories. 
Future therapeutic approaches may involve intervention in the early phase of wound healing, or in pathological 
skin conditions like psoriasis, by chemical or physical means to interfere with either target proteins like DNAH10, 
axonemal signaling, or with signaling cascades.
Limitations. The low number of patients is compensated by the power of the study design: patients served 
as their own controls and only autologous tissue was used as indicator. The utilized clinical study protocol serves 
as a relevant human model for future studies evaluating the clinical effects of various materials on full thickness 
wound healing, and provides relevant results while minimizing the required number of participants. Expression 
of DNAH10 in the epidermis was validated using immunohistochemistry in unrelated samples from control 
patients, as well as non-lesional samples from psoriasis patients’ epidermis. Meticulous care was taken to perform 
each graft harvest similarly and by applying the same amount of pressure to the dermatome to further ascertain 
equal harvesting depths in addition to the same dermatome blade depth setting.
conclusions
Our results provide a new perspective on epithelial-mesenchymal interactions and demonstrate that long-term 
persistent epidermal DNAH10 expression associates with transient regenerative and inflammatory dermal sig-
naling. We also show that DNAH10 expression is increased in inflamed psoriatic skin. These findings necessi-
tate further investigations into the acute and delayed roles of dyneins, especially DNAH10, and the axoneme in 
inflammatory epithelial-mesenchymal interactions.
Materials and Methods
A detailed description of materials and methods is available as Supplemental content.
Protocol, assignment, participant flow and follow-up. Briefly, in ten adult patients (age range 19–58 
years), one female and nine males, with large (total burn surface area range 22–45%) deep third degree burns 
(Supplementary Table S8), a wound area after excision onto fascia was randomized to receive three different 
dermal templates: 1) no dermal supplement as a control, 2) a permanent acellular dermal matrix (ADM) substi-
tution, or 3) a non-permanent cellulose dressing for induction of granulation tissue (IGT) (Fig. 1). All treatment 
sites were covered with an autologous, mainly epidermal, indicator transplant.
After a follow-up period of one year, biopsies of each site of four patients were collected, epidermal and dermal 
compartments were separated using laser-capture microdissection, and analyzed using non-targeted, label-free 
proteomics. Results were validated using immunohistochemistry and primary keratinocyte cultures.
The study was conducted according to Declaration of Helsinki principles and was approved by Research Ethics 
Committee of the Helsinki University Hospital (DNro 101/E6/2000). Written informed consent was obtained for 
all participants. This clinical trial has been registered 16/01/2019 in ISRCTN Register with ISRCTN14499986.
Data availability
The mass spectrometry proteomics data are available via ProteomeXchange with identifier PXD010852.
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